SINOVAC BIOTECH LTD

Biopharmaceutical firm developing vaccines against infectious diseases like COVID-19 and Hepatitis.

SVA | US

Overview

Corporate Details

ISIN(s):: AGP8696W1045
LEI:
Country:: United States of America
Address:: NO. 39 SHANGDI XI ROAD, 100085 BEIJING
Website:: http://www.sinovac.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sinovac Biotech Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's commercialized product portfolio includes vaccines for COVID-19 (CoronaVac®), hepatitis A (Healive®), combined hepatitis A and B (Bilive®), influenza, enterovirus 71 (Inlive®), polio, pneumonia, and chickenpox. Sinovac has achieved significant milestones, including developing a globally pioneered EV71 vaccine and China's only independently developed Hepatitis A and B combination vaccine. Several of its products have received World Health Organization (WHO) prequalification, and its CoronaVac® vaccine is included in the WHO's Emergency Use Listing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SINOVAC BIOTECH LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SINOVAC BIOTECH LTD

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for SINOVAC BIOTECH LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Co-Diagnostics, Inc. Develops patented PCR solutions for accurate infectious disease diagnostics.	United States of America	CODX
co.don AG Develops personalized cartilage cell transplants for minimally invasive joint repair.	Germany	CNW
Coeptis Therapeutics Holdings, Inc. Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.	United States of America	COEP
COGNITION THERAPEUTICS INC Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.	United States of America	CGTX
Coherus Oncology, Inc. Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.	United States of America	CHRS
COLLEGIUM PHARMACEUTICAL, INC Develops and commercializes abuse-deterrent medications for responsible chronic pain management.	United States of America	COLL
CollPlant Biotechnologies Ltd Develops rhCollagen for 3D bioprinting of tissues for regenerative & aesthetic medicine.	United States of America	CLGN
Compass Therapeutics, Inc. A clinical-stage oncology firm developing antibody therapies that engage the immune system.	United States of America	CMPX
Compugen Ltd. Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.	Israel	CGEN
COMPUGEN LTD AI-driven discovery of novel cancer immunotherapies for treatment-resistant patients.	United States of America	CGEN